Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

3.18
Delayed Data
As of Jun 22
 -0.01 / -0.31%
Today’s Change
2.14
Today|||52-Week Range
4.71
-18.04%
Year-to-Date
No recent news for Rigel Pharmaceuticals Inc.

Today’s Trading

Previous close3.19
Today’s open3.26
Day’s range3.02 - 3.28
Volume7,364,874
Average volume (3 months)2,975,540
Market cap$642.9M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+15.07%
Earnings growth (this year)-3.23%
Earnings growth (next 5 years)+108.00%
Revenue growth (last year)-78.00%
P/E ratioNM
Price/Sales109.31
Price/Book5.73

Competitors

 Today’s
change
Today’s
% change
PTGXProtagonist Therapeu...-0.01-0.15%
NVAXNovavax Inc+0.01+0.65%
MRUSMerus NV-0.41-1.82%
AGENAgenus Inc-0.07-2.80%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$4.5M
Annual profit (last year)-$78.0M
Net profit margin-1,739.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Raul R. Rodriguez
Chief Financial Officer &
Executive Vice President
Dean L. Schorno
Corporate headquarters
South San Francisco, California

Forecasts